Forecast & Rating4 analysts currently cover Catalyst Pharma, of which 0 give a positive rating. The average price target is $31.67, about 0.6% upside from the current price of $31.49. Coverage is limited, so the data is for reference only. Data as of Jun 12, 2026; this does not constitute investment advice.
Jun 12, 2026Price forecast
$31.670.56%
Forecast & RatingHold
4analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateJul 12, 2026
Forecast met43.4%
Stock price$31.48
Avg. target$34.9
High target$40
Low target$32
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.